Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling

Abstract

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.1186/s12964-019-0410-y

Publication Info

Nath, Disharee, Xiang Li, Claudia Mondragon, Dawn Post, Ming Chen, Julie R White, Anita Hryniewicz-Jankowska, Tiffany Caza, et al. (2019). Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling. Cell Communication and Signaling, 17(1). 10.1186/s12964-019-0410-y Retrieved from https://hdl.handle.net/10161/19322.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Chen

Ming Chen

Associate Professor of Pathology

Our laboratory is interested in understanding the molecular and genetic events underlying cancer progression and metastasis. The focus of our work is a series of genetically engineered mouse models that faithfully recapitulate human disease. Using a combination of mouse genetics, omics technologies, cross-species analyses and in vitro approaches, we aim to identify cancer cell–intrinsic and –extrinsic mechanisms driving metastatic cancer progression, with a long–term goal of developing new therapeutic strategies for preventing and treating metastatic disease. 


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.